Infliximab reverses suppression of cholesterol efflux proteins by TNF- α: A possible mechanism for modulation of atherogenesis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Voloshyna, Iryna ^a   Seshadri, Sangeetha ^a   Anwar, Kamran ^a   Littlefield, Michael J ^a   Belilos, Elise ^a   Carsons, Steven E ^a   Reiss, Allison B ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; INFLIXIMAB; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; ORPHAN NUCLEAR RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MONOCYTE; TRANSPORT AT THE CELLULAR LEVEL;

ANTIBODIES, MONOCLONAL; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTANETRIOL 26-MONOOXYGENASE; CHOLESTEROL; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; ORPHAN NUCLEAR RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893740802     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/312647     Document Type: Article

References (28)

1. Szekanecz Z., Kerekes G., Dér H., Sándor Z., Szabó Z., Végvári A., Simkovics E., Soós L., Szentpétery Á., Besenyei T., Szücs G., Szántó S., Tamási L., Szegedi G., Shoenfeld Y., Soltész P., Accelerated atherosclerosis in rheumatoid arthritis. Annals of the New York Academy of Sciences 2007 1108 349 358 2-s2.0-34948903757 10.1196/annals.1422.036 (Pubitemid 47528747)
2. Maradit-Kremers H., Nicola P. J., Crowson C. S., Ballman K. V., Gabriel S. E., Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis and Rheumatism 2005 52 3 722 732 2-s2.0-14944358734 10.1002/art.20878 (Pubitemid 40365093)
3. Asanuma Y., Oeser A., Shintani A. K., Turner E., Olsen N., Fazio S., Linton M. F., Raggi P., Stein C. M., Premature coronary-artery atherosclerosis in systemic lupus erythematosus. The New England Journal of Medicine 2003 349 25 2407 2415 2-s2.0-0347922145 10.1056/NEJMoa035611 (Pubitemid 37542989)
4. Kim S. C., Yelin E., Tonner C., Solomon D. H., Changes in use of disease modifying anti-rheumatic drugs for rheumatoid Arthritis in the U.S. for the period 1983-2009. Arthritis Care & Research 2013 65 9 1529 1533 10.1002/acr.21997
5. Lipsky P. E., van der Heijde D. M. F. M., St. Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M., Harriman G. R., Maini R. N., Infliximab and methotrexate in the treatment of rheumatoid arthritis. The New England Journal of Medicine 2000 343 22 1594 1602 2-s2.0-0034735842 10.1056/NEJM200011303432202 (Pubitemid 32162982)
6. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005 352 16 1685 1626 2-s2.0-17644412023 10.1056/NEJMra043430 (Pubitemid 40530235)
7. Bartoloni E., Alunno A., Bistoni O., Gerli R., How early is the atherosclerotic risk in rheumatoid arthritis? Autoimmunity Reviews 2010 9 10 701 707 2-s2.0-77955267766 10.1016/j.autrev.2010.06.001
8. Sprague A. H., Khalil R. A., Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology 2009 78 6 539 552 2-s2.0-67651146363 10.1016/j.bcp.2009.04.029
9. Tetta C., Camussi G., Modena V., di Vittorio C., Baglioni C., Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Annals of the Rheumatic Diseases 1990 49 9 665 667 2-s2.0-0025170855 (Pubitemid 20279114)
10. Tracey D., Klareskog L., Sasso E. H., Salfeld J. G., Tak P. P., Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacology and Therapeutics 2008 117 2 244 279 2-s2.0-38549176118 10.1016/j.pharmthera.2007.10.001
11. Popa C., Netea M. G., Radstake T., van der Meer J. W. M., Stalenhoef A. F. H., van Riel P. L. C. M., Barerra P., Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Annals of the Rheumatic Diseases 2005 64 2 303 305 2-s2.0-13244252637 10.1136/ard.2004.023119 (Pubitemid 40193632)
12. Castro K. R., Aikawa N. E., Saad C. G., Moraes J. C. B., Medeiros A. C., Mota L. M. H., Silva C. A. A., Bonfá E., Carvalho J. F., Infliximab induces increase in triglyceride levels in psoriatic arthritis patients. Clinical and Developmental Immunology 2011 2011 5 2-s2.0-80052777107 10.1155/2011/352686 352686
13. Cuchel M., Rader D. J., Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 2006 113 21 2548 2555 2-s2.0-33745132444 10.1161/CIRCULATIONAHA.104.475715 (Pubitemid 43948034)
14. Voloshyna I., Reiss A. B., The ABC transporters in lipid flux and atherosclerosis. Progress in Lipid Research 2011 50 3 213 224 2-s2.0-79952705101 10.1016/j.plipres.2011.02.001
15. Laffitte B. A., Joseph S. B., Walczak R., Pei L., Wilpitz D. C., Collins J. L., Tontonoz P., Autoregulation of the human liver X receptor α promoter. Molecular and Cellular Biology 2001 21 22 7558 7568 2-s2.0-0034773966 10.1128/MCB.21.22.7558-7568.2001 (Pubitemid 32988767)
16. Whitney K. D., Watson M. A., Goodwin B., Galardi C. M., Maglich J. M., Wilson J. G., Willson T. M., Collins J. L., Kliewer S. A., Liver X Receptor (LXR) regulation of the LXR α gene in human macrophages. Journal of Biological Chemistry 2001 276 47 43509 43515 2-s2.0-0035941285 10.1074/jbc.M106155200
17. Reiss A. B., Awadallah N. W., Malhotra S., Montesinos M. C., Chan E. S. L., Javitt N. B., Cronstein B. N., Immune complexes and IFN- γ decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. Journal of Lipid Research 2001 42 11 1913 1922 2-s2.0-0035203142 (Pubitemid 33116723)
18. Reiss A. B., Patel C. A., Rahman M. M., Chan E. S. L., Hasneen K., Montesinos M. C., Trachman J. D., Cronstein B. N., Interferon- γ impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Medical Science Monitor 2004 10 11 BR420 BR425 2-s2.0-9144222145 (Pubitemid 39546030)
19. Jiang J., Mo Z.-C., Yin K., Zhao G.-J., Lv Y.-C., Ouyang X.-P., Jiang Z.-S., Fu Y., Tang C.-K., Epigallocatechin-3-gallate prevents TNF- α -induced NF- B activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells. International Journal of Molecular Medicine 2012 29 5 946 956 2-s2.0-84858273322 10.3892/ijmm.2012.924
20. Wang Y., Moser A. H., Shigenaga J. K., Grunfeld C., Feingold K. R., Downregulation of liver X receptor- α in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. Journal of Lipid Research 2005 46 11 2377 2387 2-s2.0-27444439757 10.1194/jlr.M500134-JLR200 (Pubitemid 41532526)
21. St.clair E. W., Wagner C. L., Fasanmade A. A., Wang B., Schaible T., Kavanaugh A., Keystone E. C., The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 2002 46 6 1451 1459 2-s2.0-0036269445 10.1002/art.10302 (Pubitemid 34620190)
22. Dervieux T., Weinblatt M. E., Kivitz A., Kremer J. M., Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis. Annals of the Rheumatic Diseases 2013 72 6 908 910 10.1136/annrheumdis-2012-202591
23. Mei C.-L., Chen Z.-J., Liao Y.-H., Wang Y.-F., Peng H.-Y., Chen Y., Interleukin-10 inhibits the down-regulation of ATP binding cassette transporter A1 by tumour necrosis factor-alpha in THP-1 macrophage-derived foam cells. Cell Biology International 2007 31 12 1456 1461 2-s2.0-35348959983 10.1016/j.cellbi.2007.06.009 (Pubitemid 47599975)
24. Field F. J., Watt K., Mathur S. N., TNF- α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. Journal of Lipid Research 2010 51 6 1407 1415 2-s2.0-77952739913 10.1194/jlr.M002410
25. Sankaramarayanan S., Oram J. F., Asztalos B. F., Vaughan A. M., Lund-Katz S., Adorni M. P., Phillips M. C., Rothblat G. H., Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. Journal of Lipid Research 2009 50 2 275 284 2-s2.0-64749090059 10.1194/jlr.M800362-JLR200
26. Voloshyna I., Carsons S., Littlefield M. J., Rieger J. M., Figler R., Reiss A. B., Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells. Biochimica et Biophysica Acta 1831 2 407 416
27. Voloshyna I., Hai O., Littlefield M. J., Carsons S., Reiss A. B., Resveratrolmediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPAR γ and adenosine. European Journal of Pharmacology 2013 698 1-3 299 309 10.1016/j.ejphar.2012.08.024
28. Tian J., Chen J. W., Gao J. S., Li L., Xie X., Resveratrol inhibits TNF- α -induced IL-1 β MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatology International 2013 33 7 1829 1835 10.1007/s00296-012-2657-0